Literature DB >> 16409146

Celiac disease.

Peter H R Green1, Bana Jabri.   

Abstract

Celiac disease is an autoimmune disease that occurs in genetically predisposed individuals as the result of an immune response to gluten. This immune response occurs in both the lamina propria and the epithelium of the small intestine. There is a close link to HLA DQ2 and DQ8, although these HLA genes account for only 40% of the genetic influence. Environmental factors, such as the amount and timing of gluten administration in infancy, as well as breastfeeding, influence the disease. Serologic screening studies that use sensitive and specific antibody tests have revealed the disease to be common, occurring in approximately 1% of the population. Clinical presentations are diverse and atypical; the majority of patients lack diarrhea. Therapy is a gluten-free diet that requires avoidance of wheat, rye, and barley, although there is potential for other therapies based on our understanding of the pathophysiology of the disease.

Entities:  

Mesh:

Year:  2006        PMID: 16409146     DOI: 10.1146/annurev.med.57.051804.122404

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  45 in total

1.  Serology of celiac disease in gluten-sensitive ataxia or neuropathy: role of deamidated gliadin antibody.

Authors:  Shahrooz Rashtak; Shadi Rashtak; Melissa R Snyder; Sean J Pittock; Tsung-Teh Wu; Manish J Gandhi; Joseph A Murray
Journal:  J Neuroimmunol       Date:  2010-11-06       Impact factor: 3.478

Review 2.  Hematologic manifestations of celiac disease.

Authors:  Thorvardur R Halfdanarson; Mark R Litzow; Joseph A Murray
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

3.  Co-occurrence of IgA antibodies against ethanol metabolites and tissue transglutaminase in alcohol consumers: correlation with proinflammatory cytokines and markers of fibrogenesis.

Authors:  Heidi Koivisto; Johanna Hietala; Petra Anttila; Onni Niemelä
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

Review 4.  Oat: unique among the cereals.

Authors:  Masood Sadiq Butt; Muhammad Tahir-Nadeem; Muhammad Kashif Iqbal Khan; Rabia Shabir; Mehmood S Butt
Journal:  Eur J Nutr       Date:  2008-02-26       Impact factor: 5.614

5.  Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy.

Authors:  Douglas D McCarthy; Julie Kujawa; Cheryl Wilson; Adrian Papandile; Urjana Poreci; Elisa A Porfilio; Lesley Ward; Melissa A E Lawson; Andrew J Macpherson; Kathy D McCoy; York Pei; Lea Novak; Jeannette Y Lee; Bruce A Julian; Jan Novak; Ann Ranger; Jennifer L Gommerman; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2011-09-01       Impact factor: 14.808

6.  Elevated Total Iron-Binding Capacity Is Associated with an Increased Risk of Celiac Disease.

Authors:  Dorothea Letner; Joanna Peloquin; Jacquelyn Durand; Anna Rutherford; Vijay Yajnik; Hamed Khalili; John Garber
Journal:  Dig Dis Sci       Date:  2015-07-15       Impact factor: 3.199

Review 7.  Testing for gluten-related disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity.

Authors:  David Armstrong; Andrew C Don-Wauchope; Elena F Verdu
Journal:  Can J Gastroenterol       Date:  2011-04       Impact factor: 3.522

Review 8.  Mannose-binding lectin and maladies of the bowel and liver.

Authors:  Daniel-L Worthley; Peter-G Bardy; David-L Gordon; Charles-G Mullighan
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

9.  Performance of serology assays for diagnosing celiac disease in a clinical setting.

Authors:  Miriam Parizade; Yoram Bujanover; Batya Weiss; Vered Nachmias; Bracha Shainberg
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

10.  Host responses to intestinal microbial antigens in gluten-sensitive mice.

Authors:  Jane M Natividad; Xianxi Huang; Emma Slack; Jennifer Jury; Yolanda Sanz; Chella David; Emmanuel Denou; Pinchang Yang; Joseph Murray; Kathy D McCoy; Elena F Verdú
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.